MFG
EDIT icon

Merit Financial Group’s Editas Medicine EDIT Stock Holding History

Merit Financial Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.5K Sell
11,566
-10
-0.1% -$29 ﹤0.01% 2313
2026
Q1 		$28.6K Buy
+11,576
New +$24.5K ﹤0.01% 2086

Other funds holding EDIT

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TWM
Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return

Merit Financial Group's EDIT Position: Q2 2026 in Review

Merit Financial Group reduced its Editas Medicine (EDIT) stake by 0.09% in Q2 2026, selling an estimated $29 and leaving 11,566 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

Merit Financial Group first reported a position in EDIT in Q1 2026 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Merit Financial Group held 11,566 shares of Editas Medicine worth $37.5K as of Q2 2026.
  • Merit Financial Group sold 10 Editas Medicine shares in Q2 2026, an estimated $29.
  • Editas Medicine made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2313 holding.
  • Merit Financial Group first reported a position in Editas Medicine in Q1 2026 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.